Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
For full access to this article login to GEN Select now.
New Biomolecules for Cancer Treatment
Real Hope for Safer Drugs on the Horizon
- At the recent 9th European Biotech Crossroads meeting in Lille, France, Nigel Courtenay-Luck, Ph.D., CSO of Antisoma (www.anti soma.com), presented encouraging safety data from a Phase I study of a new type of biomolecule known as an aptamer. According to Dr. Courtenay-Luck, an aptamer has similar properties to ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.